Treating periodontal disease not only improves oral health, it also reduces a chronic infectious burden on patients’ immune system. Unfortunately, it is one of the most underdiagnosed diseases. 47% of American adults have chronic periodontitis, but, according to Dental Intel, only 8% of patients get treatment planned for D4341 and D4342. Of that 8%, only half accept the treatment. Without a diagnosis, patients cannot make informed decisions or get the care they need.
Antibiotic adjunctive therapies have a temporary, limited effect. This is because biofilms repopulate after usage and because we are in the post-antibiotic age.  Several studies and advances have re-shaped the dental strategies in treating periodontal disease.  In this highly informative and entertaining presentation, Dr. Gupta shares several updates in the treatment of periodontal disease and peri-implantitis.

Objectives:
Identify the benefits and limitations of antimicrobials with oxidative and oxygenating reactions for biofilm management.
Recognize patient candidates who would most benefit from the most advanced periodontal strategies
Evaluate clinical cases and the efficacy of these new strategies in treatment.        

This course is provided by EMS Electro Medical Systems.